Leadership Overview
Crinetics Pharmaceuticals has 6 executives leading key functions including finance, operations, human resources, and legal.
Driven by a commitment to patient well-being, Crinetics Pharmaceuticals develops essential therapies for endocrine diseases, aiming to simplify lives and provide effective disease control through collaboration with healthcare practitioners and by addressing critical market needs for investors.
Driven by a commitment to patient well-being, Crinetics Pharmaceuticals develops essential therapies for endocrine diseases, aiming to simplify lives and provide effective disease control through collaboration with healthcare practitioners and by addressing critical market needs for investors.
Leadership Roles at Crinetics Pharmaceuticals
Tobin Schilke - Chief Financial Officer
Tobin Schilke, the Chief Financial Officer at Crinetics Pharmaceuticals, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, the Chief Financial Officer ensures robust financial health and supports the company's growth objectives. This leadership position involves managing capital allocation, investor relations, and risk management to build sustainable value. By optimizing financial strategies, Tobin Schilke directly contributes to the company's ability to fund the development of much-needed therapies for endocrine diseases. The Chief Financial Officer's oversight extends to ensuring compliance with financial regulations and driving efficiency across all fiscal activities, thereby reinforcing the company's market position and investor confidence.

Niccole Le - Chief of Staff To the Chief Operating Officer and Head of Alliance Management
Niccole Le, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management at Crinetics Pharmaceuticals, provides critical operational support and manages strategic partnerships. This dual role involves streamlining operations for the Chief Operating Officer while also spearheading alliance management initiatives to foster key collaborations. Overseeing the coordination of cross-functional projects, the Chief of Staff To the Chief Operating Officer and Head of Alliance Management ensures alignment with company goals and facilitates efficient execution of strategic plans. Niccole Le's responsibilities include driving the success of external partnerships, which are vital for developing and delivering therapies for endocrine diseases. The Head of Alliance Management ensures that collaborative efforts translate into tangible progress, supporting the company's mission to solve real problems for patients and healthcare practitioners.
Rafael Marino - Affairs Operations Senior Director, Medical & Chief of Staff
Rafael Marino, the Affairs Operations Senior Director, Medical & Chief of Staff at Crinetics Pharmaceuticals, leads critical medical operations and provides executive support. This senior role encompasses overseeing the strategic direction of medical affairs operations, ensuring alignment with the company's therapeutic development goals for endocrine diseases. As Chief of Staff, Rafael Marino facilitates communication and execution across various departments, enhancing operational efficiency and strategic implementation. The Affairs Operations Senior Director, Medical role involves managing key medical initiatives and ensuring compliance with industry standards. By driving effective medical operations, Marino supports the company's commitment to providing patients with therapies that offer effective disease control and simplicity. This leadership ensures that medical strategies directly address patient needs and support healthcare practitioners.
Natalie Berwald - Executive Assistant To the Chief Human Resources Officer
Natalie Berwald, the Executive Assistant To the Chief Human Resources Officer at Crinetics Pharmaceuticals, provides essential administrative and strategic support to the human resources function. This role is crucial for ensuring the smooth operation of HR initiatives that support the company's mission of developing therapies for endocrine diseases. The Executive Assistant To the Chief Human Resources Officer manages complex scheduling, coordinates meetings, and assists with the implementation of HR policies and programs. Natalie Berwald's contributions are vital for maintaining organizational efficiency and supporting the Chief Human Resources Officer in fostering a productive work environment. This support directly impacts the company's ability to attract and retain talent necessary for advancing its therapeutic development pipeline and meeting market needs.
Adriana Cabre - Chief Human Resources Officer
Adriana Cabre, the Chief Human Resources Officer at Crinetics Pharmaceuticals, directs all human capital strategies and organizational development initiatives. Overseeing talent acquisition, employee relations, and compensation and benefits, the Chief Human Resources Officer ensures a robust workforce capable of driving innovation in endocrine disease therapies. This leadership position involves cultivating a company culture that supports patient-centricity and operational excellence. By aligning HR strategies with business objectives, Adriana Cabre fosters an environment where employees can effectively develop much-needed therapies and address real market needs. The Chief Human Resources Officer's focus on talent management and employee engagement is critical for the company's long-term success and its ability to provide effective disease control and simplicity for patients.
Garlan Adams - Chief Legal Officer
Garlan Adams, the Chief Legal Officer at Crinetics Pharmaceuticals, oversees all legal affairs and ensures corporate compliance. Directing legal strategy, risk management, and intellectual property protection, the Chief Legal Officer safeguards the company's interests as it develops therapies for endocrine diseases. This critical role involves advising the executive team and the board on legal matters, ensuring adherence to regulatory requirements, and managing litigation. By providing expert legal counsel, Garlan Adams supports the company's mission to solve real problems for patients and healthcare practitioners. The Chief Legal Officer's oversight is essential for navigating the complex regulatory landscape of the pharmaceutical industry, thereby building value for investors and ensuring the integrity of the company's operations.

Explore Leadership Teams in Manufacturing
Abbott is a global healthcare company that develops and delivers a broad range of medical technologies, diagnostics, nutrition products, and branded generic medicines. The company is focused on improving health outcomes and helping people live healthier lives across all stages of life. Its mission centers on creating innovative solutions that address important medical needs, including chronic disease management, cardiovascular care, diabetes care, and pain management.
Company Leadership PH
AB
SG
MW
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, founded in 2015 and publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.
Company Leadership


CU
诺诚健华 is focused on developing innovative drugs to address significant unmet clinical needs in the fields of malignant tumors and autoimmune diseases. The company possesses comprehensive research and commercialization capabilities, aiming to create first-in-class or best-in-class therapies for global markets. With a strong pipeline in hematological malignancies, autoimmune diseases, and solid tumors, 诺诚健华 is committed to delivering high-quality innovative medicines that benefit patients worldwide. The company is led by co-founder and CEO Dr. 崔霁松, who emphasizes the importance of scientific-driven innovation.
Company Leadership NB
KG
SZ
IOLCP is a leading manufacturer and supplier of Active Pharmaceutical Ingredients (API) and specialty chemicals, including Ethyl Acetate, which is recognized for its environmentally friendly properties. The company serves pharmaceutical companies globally by providing essential products for key medicines and is committed to sustainable practices and corporate social responsibility. With a strong focus on research and development, IOLCP aims to expand its value-added services in the API market while fostering green chemistry. The organization prides itself on its dedicated workforce and aims to create lasting value for both the planet and communities.
Company Leadership DS
PK